Hypoxic regulation of macrophage migration and function via fibroblast reprogramming in pancreatic cancer

通过胰腺癌成纤维细胞重编程对巨噬细胞迁移和功能的缺氧调节

基本信息

项目摘要

PROJECT SUMMARY Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer-related deaths in the United States despite representing only 2% of all cancer cases. PDAC is characterized by an extensive fibroinflammatory stroma and a hypoxic microenvironment, which contributes to disease progression and therapeutic resistance. Macrophages and cancer-associated fibroblasts (CAFs) are the predominant cell types within the PDAC stroma. Macrophages are a major immunosuppressive population in PDAC. These cells are highly plastic and, as a result, their environment plays an important role in regulating their function. Macrophages adapt to hypoxia, a condition of low oxygen availability, primarily through the stabilization of oxygen-liable transcription factors called hypoxia-inducible factors (HIFs). Although PDAC is extremely hypoxic and both the tumor cells and stromal cells experience hypoxia, the effects of hypoxia and HIFs on macrophages and their communication with other stromal cells in PDAC remain largely unknown. Our group has recently found that hypoxia promotes the acquisition of inflammatory cancer-associated fibroblasts (inflammatory CAFs), a recently defined PDAC fibroblast subtype that produces high levels of inflammatory cytokines and chemokines. By injecting a hypoxia probe into mice bearing PDAC, we have observed that inflammatory CAFs and macrophages predominantly reside in hypoxic tumor regions compared with normoxic regions whereas T cells are largely excluded from hypoxic tumor areas. Based on these preliminary data, I hypothesize that inflammatory fibroblasts induced by hypoxia promote macrophage infiltration into hypoxic tumor regions and facilitate an immunosuppressive macrophage phenotype. This hypothesis will be investigated with the following two Aims: (1) to determine the role of hypoxia-induced fibroblast-secreted factors in regulating macrophage migration and function in PDAC and (2) to define the role of macrophage HIFs in regulating macrophage migration and function in PDAC. To complete Aim 1, I will culture macrophages with conditioned media derived from mono- and co- cultures of pancreatic tumor cells and fibroblasts under either hypoxia or normoxia, and then assess the expression of immunosuppressive macrophage markers as well as their migration. To complete Aim 2, I will culture HIF1α-deficient and HIF2α-deficient macrophages under hypoxia with fresh media or conditioned media from co-cultures of pancreatic tumor cells and fibroblasts under hypoxia. Then I will assess the expression of immunosuppressive markers in these macrophages and evaluate their migration. Finally, I will define the role of macrophage HIFs in mediating pancreatic tumorigenesis using orthotopic tumors from mice lacking myeloid expression of HIF1ɑ or HIF2ɑ. My proposal will provide new insights into how hypoxia promotes an immunosuppressive PDAC microenvironment by modulating the macrophage-fibroblast crosstalk, and ultimately inform strategies to overcome resistance to immunotherapy.
项目概要 胰腺导管腺癌 (PDAC) 是美国癌症相关死亡的第三大原因 尽管各州仅占所有癌症病例的 2%。 PDAC 的特点是广泛 纤维炎症基质和缺氧微环境,这有助于疾病进展和 治疗抵抗。巨噬细胞和癌症相关成纤维细胞 (CAF) 是主要的细胞类型 在 PDAC 基质内。巨噬细胞是 PDAC 中的主要免疫抑制群体。这些细胞是 高度可塑性,因此,它们的环境在调节它们的功能方面发挥着重要作用。巨噬细胞 适应缺氧,即氧气供应量低的情况,主要是通过稳定氧气不稳定的状态来适应 转录因子称为缺氧诱导因子(HIF)。尽管 PDAC 极度缺氧并且 肿瘤细胞和基质细胞经历缺氧,缺氧和HIF对巨噬细胞及其作用的影响 PDAC 中与其他基质细胞的通讯仍然很大程度上未知。我们小组最近发现 缺氧促进炎症性癌症相关成纤维细胞(炎症性 CAF)的获得,这是最近发现的一种 确定的 PDAC 成纤维细胞亚型产生高水平的炎症细胞因子和趋化因子。经过 通过向携带 PDAC 的小鼠注射缺氧探针,我们观察到炎症性 CAF 和巨噬细胞 与含氧量正常的区域相比,T 细胞主要存在于缺氧的肿瘤区域,而 T 细胞则主要分布在缺氧的肿瘤区域。 排除缺氧肿瘤区域。根据这些初步数据,我假设炎症成纤维细胞 缺氧诱导促进巨噬细胞浸润缺氧肿瘤区域并促进 免疫抑制巨噬细胞表型。该假设将通过以下两个目标进行研究: (1)确定缺氧诱导的成纤维细胞分泌因子在调节巨噬细胞迁移和迁移中的作用 (2) 定义巨噬细胞 HIF 在调节巨噬细胞迁移和功能中的作用 在 PDAC 中。为了完成目标 1,我将使用来自单和共-的条件培养基培养巨噬细胞 在缺氧或常氧条件下培养胰腺肿瘤细胞和成纤维细胞,然后评估 免疫抑制巨噬细胞标记物的表达及其迁移。为了完成目标2,我会 用新鲜培养基或条件培养基在缺氧条件下培养 HIF1α 缺陷型和 HIF2α 缺陷型巨噬细胞 来自缺氧条件下胰腺肿瘤细胞和成纤维细胞的共培养。然后我将评估的表达 这些巨噬细胞中的免疫抑制标记并评估它们的迁移。最后,我将定义角色 巨噬细胞 HIF 在利用缺乏骨髓小鼠的原位肿瘤介导胰腺肿瘤发生中的作用 HIF1ɑ 或 HIF2ɑ 的表达。我的建议将为缺氧如何促进 通过调节巨噬细胞-成纤维细胞串扰来抑制免疫抑制 PDAC 微环境,最终 提供克服免疫治疗耐药性的策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sean Matthew Hannifin其他文献

Sean Matthew Hannifin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

A methodology to connect functionalized gonadal constructs to a chick embryo through mechanically induced blood vessels from an egg
一种通过鸡蛋机械诱导血管将功能化性腺结构连接到鸡胚胎的方法
  • 批准号:
    24K15741
  • 财政年份:
    2024
  • 资助金额:
    $ 4.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
All-in-One Smart Artificial Blood Vessels
一体化智能人造血管
  • 批准号:
    EP/X027171/2
  • 财政年份:
    2024
  • 资助金额:
    $ 4.08万
  • 项目类别:
    Fellowship
Development of nextgeneration cellular artificial blood vessels for coronary artery bypass surgery using bio-3D printer
使用生物 3D 打印机开发用于冠状动脉搭桥手术的下一代细胞人造血管
  • 批准号:
    23H02991
  • 财政年份:
    2023
  • 资助金额:
    $ 4.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Tissue engineered blood vessels
组织工程血管
  • 批准号:
    2891099
  • 财政年份:
    2023
  • 资助金额:
    $ 4.08万
  • 项目类别:
    Studentship
ealization of navigation surgery by automatic recognition of stomach and surrounding blood vessels using artificial intelligence
利用人工智能自动识别胃及周围血管,实现导航手术
  • 批准号:
    23K07176
  • 财政年份:
    2023
  • 资助金额:
    $ 4.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Realtime observation and optical control of living microbial probes in blood vessels
血管内活微生物探针的实时观察和光学控制
  • 批准号:
    23H00551
  • 财政年份:
    2023
  • 资助金额:
    $ 4.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Creation of a technique for visualization of stress concentration in blood and blood vessels by combined measurement of photoelasticity and ultrasonic Doppler velocimetry
通过光弹性和超声多普勒测速的组合测量,创建了一种可视化血管中应力集中的技术
  • 批准号:
    23H01343
  • 财政年份:
    2023
  • 资助金额:
    $ 4.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Shear stress-activated synthetic cells for targeted drug release in stenotic blood vessels
剪切应力激活合成细胞用于狭窄血管中的靶向药物释放
  • 批准号:
    10749217
  • 财政年份:
    2023
  • 资助金额:
    $ 4.08万
  • 项目类别:
Creation of 3D tissue culture system integrated with blood vessels and autonomic nerves
打造血管与植物神经融合的3D组织培养系统
  • 批准号:
    23H01827
  • 财政年份:
    2023
  • 资助金额:
    $ 4.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Biological function of osteoporotic drugs on bone-specific blood vessels and perivascular cells
骨质疏松药物对骨特异性血管和血管周围细胞的生物学功能
  • 批准号:
    22K21006
  • 财政年份:
    2022
  • 资助金额:
    $ 4.08万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了